Mimedx Group, Inc. (MDXG)

Name: Mimedx Group, Inc. (MDXG) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

SEC name MIMEDX GROUP, INC. · CIK 0001376339 · Nasdaq · Surgical & Medical Instruments & Apparatus

Sector Manufacturing
Fiscal year ends Dec 31

For the year ended 2025-12-31, Mimedx Group, Inc. reported revenue of $418.63M. Revenue grew 20.0% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $355.17M.

Key ratios (year ended 2025-12-31)

82.6%

Gross margin

15.3%

Operating margin

11.6%

Net margin

18.9%

Return on year-end equity

20.0%

Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-16

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Revenue	$355.17M	$418.63M	$348.88M	$321.48M	$267.84M	$242.02M	$248.23M	$299.25M	$359.11M	$321.14M	$221.71M
Cost of Revenue	$75.12M	$73.01M	$60.07M	$54.63M	$48.32M	$39.63M	$39.33M	$43.08M	$36.39M	$35.22M	$30.94M
Gross Profit	$280.05M	$345.62M	$288.81M	$266.84M	$219.53M	$202.39M	$208.90M	$256.17M	$322.73M	$285.92M	$190.77M
R&D Expense	$15.38M	$15.10M	$12.34M	$12.66M	$12.70M	$9.93M	$11.71M	$11.14M	$15.77M	$17.90M	$14.34M
Operating Income	$8.75M	$63.89M	$58.87M	$37.12M	-$14.73M	-$7.05M	-$45.40M	-$21.16M	-$3.92M	$46.22M	$884.0K
Depreciation & Amortization	n/a	$14.88M	$6.04M	$3.43M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
EBITDA	n/a	$78.77M	$64.91M	$40.54M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Net Income	$6.24M	$48.58M	$42.42M	$58.23M	-$30.20M	-$10.29M	-$49.28M	-$25.58M	-$29.98M	$64.73M	$390.0K
EPS (Diluted)	n/a	$0.32	$0.28	$0.37	-$0.33	-$0.15	-$0.77	-$0.24	-$0.28	$0.56	$0.00
Total Assets	$281.00M	$342.65M	$263.92M	$239.05M	$171.43M	$187.93M	$202.03M	$167.17M	$122.84M	$121.25M	$117.27M
Total Liabilities	$65.00M	$86.11M	$70.81M	$96.33M	$96.92M	$95.35M	$110.61M	$132.77M	$73.19M	$47.46M	$69.21M
Long-Term Debt	n/a	$18.00M	$19.00M	$50.00M	$50.00M	$50.00M	$50.00M	$73.12M	n/a	n/a	n/a
Shareholders' Equity	$216.00M	$256.55M	$193.11M	$142.72M	-$17.99M	$82.0K	-$150.0K	$34.40M	$49.66M	$73.80M	$48.07M
Cash & Equivalents	$135.84M	$166.12M	$104.42M	$82.00M	$65.95M	$87.08M	$95.81M	$69.07M	$45.12M	$27.48M	$30.32M
Operating Cash Flow	$46.15M	$74.00M	$66.20M	$26.77M	-$17.89M	-$1.98M	-$30.26M	-$39.41M	$35.80M	$62.94M	$23.85M
Capital Expenditures	n/a	n/a	n/a	$1.99M	$1.51M	$3.22M	n/a	n/a	n/a	n/a	n/a
Free Cash Flow	n/a	n/a	n/a	$24.79M	-$19.41M	-$5.20M	n/a	n/a	n/a	n/a	n/a
Share Repurchases	$12.47M	$0	$0	$9.52M	$0	$0	$900.0K	n/a	$7.60M	$68.30M	$10.40M
Shares Outstanding	145.72M	148.09M	146.93M	146.23M	113.71M	111.93M	110.93M	110.82M	109.10M	109.35M	109.86M
Weighted Average Diluted Shares	n/a	149.72M	149.05M	145.96M	112.91M	110.35M	108.26M	106.95M	105.60M	116.11M	112.65M
EPS (Basic)	n/a	$0.33	$0.29	$0.40	-$0.33	-$0.15	-$0.77	-$0.24	-$0.28	$0.61	$0.00

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView